Stopping smoking cuts the risk of some cancers quickly in people with HIV
How should HIV self-testing services be provided?
Unique case of PrEP failure without drug resistance reported from Amsterdam
New HIV infections fall in the US, but demographic and geographic disparities persist
Isoniazid preventive treatment reduces the risk of death by 37% in people living with HIV
Treatment or watchful waiting for cervical abnormalities in women with HIV?
Tenofovir/emtricitabine/efavirenz less likely to cause adverse birth outcomes than other regimens, Botswana study finds
Experimental STI prophylaxis in PrEP users produces big drops in syphilis and chlamydia infections but not in gonorrhoea
Changes in viral suppression over time reveal disparities in HIV care in the United States
Dual antiretroviral regimen maintains durable HIV suppression after switch
Infants treated within days of birth can clear HIV reservoir rapidly
Treatment-as-prevention study sees substantial levels of transmitted drug resistance in participants, but no impact on treatment
Point-of-care test improves infant HIV diagnosis rate, treatment starts and retention in care
Integrase inhibitor bictegravir matches dolutegravir for first-line HIV treatment
A benign circle: how a combination of factors has reduced HIV infections in one of the hardest-hit parts of Africa
